Evidence map›Paper›PMID 31085128›Full record

ArticleTuberculosis (Edinburgh, Scotland)2019

Vitamin D modulates human macrophage response to Mycobacterium tuberculosis DNA.

Jorge L Cervantes, Esther Oak, John Garcia, Hongfei Liu, Paolo A Lorenzini, Deepika Batra, Arvind Chhabra, Juan C Salazar, Xavier Roca

Open access · greenAbstract read
In one paragraph

Article in Tuberculosis (Edinburgh, Scotland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Nutrients · 2024
    Article
  6. Article
  7. Article
  8. The Immunomodulatory Properties of Vitamin D.Mediterranean journal of rheumatology · 2022
    Review
  9. Human macrophage polarization in the response toCurrent research in microbial sciences · 2021
    Article
  10. New management approaches to tuberculosis in people living with HIV.Current opinion in infectious diseases · 2021
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Jorge L CervantesTexas Tech University Health Sciences Center, Paul L. Foster School of Medicine, El Paso, TX, USA. Electronic address: jorge.cervantes@ttuhsc.edu.
Esther OakUniversity of New England, College of Dental Medicine, Portland, ME, USA.
John GarciaUniversity of Connecticut Health, School of Public Health, Farmington, CT, USA.
Hongfei LiuSchool of Biological Sciences, Nanyang Technological University, Singapore.
Paolo A LorenziniSchool of Biological Sciences, Nanyang Technological University, Singapore; Nanyang Institute of Technology in Health and Medicine, Interdisciplinary Graduate School, Nanyang Technological University, Singapore.
Deepika BatraStem Cell Institute, Amity University Haryana, Manesar, Gurugram, Haryana, India.
Arvind ChhabraStem Cell Institute, Amity University Haryana, Manesar, Gurugram, Haryana, India.
Juan C SalazarUniversity of Connecticut Health, Department of Pediatrics, Farmington, CT, USA; Connecticut Children's Medical Center, Hartford, CT, USA.
Xavier RocaSchool of Biological Sciences, Nanyang Technological University, Singapore.
Nanyang Technological University · SGConnecticut Children's Medical Center · USNew England College · USTexas Tech University · USUConn Health · US

Funding

Phagosomal Signals Shape Inflammatory Responses to B. BurgdorferiR01AI090166 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI SALAZAR, JUAN C · 2011 to 2015
$2.1M
NIAID NIH HHS R01 AI090166
6 · The paper itself

Abstract

Mycobacterium tuberculosis (Mtb) is a facultative intracellular pathogen that infects macrophages where it avoids elimination by interfering with host defense mechanisms, including phago-lysosome fusion. Endosomal Toll-like receptors (TLRs) generate Type I Interferons (IFNs), which are associated with active tuberculosis (TB). We aimed to explore if DNA from different Mtb lineages lead to differences in the inflammatory response of human monocytic/macrophage cells. THP-1 cells which express two inducible reporter constructs for interferons (IFNs) as well as for NF-κB, were stimulated via endosomal delivery of Mtb DNA as a nanocomplex with PEI. DNA from different Mtb phylogenetic lineages elicited differential inflammatory responses in human macrophages. An initial relatively weak IRF-mediated response to DNA from HN878 and H37Rv increased if the cells were pre-treated with Vitamin D (Vit D) for 72 h. RNAseq of THP-1 under different transformation conditions showed that pre-treatment with Vit D upregulated several TLR9 variants, as well as genes involved in inflammatory immune response to infection, immune cell activation, Type I IFN regulation, and regulation of inflammation. Vit D appears to be important in increasing low IRF responses to DNA from certain lineages of Mtb. Variations in the IRF-mediated response to DNA derived from different Mtb genotypes are potentially important in the pathogenesis of tuberculosis since Type I IFN responses are associated with active disease. The role of Vit D in these responses could also translate into future therapeutic approaches.

Indexed as

CalcitriolDNA, BacterialMacrophagesMycobacterium tuberculosisBacterial ProteinsHost-Pathogen InteractionsHumansInterferon-gammaInterferon Regulatory FactorsNF-kappa BTHP-1 CellsToll-Like Receptor 9TuberculosisBacterial ProteinsCalcitriolDNA, BacterialInterferon-gammaInterferon Regulatory FactorsNF-kappa BTLR9 protein, humanToll-Like Receptor 9Mycobacterium tuberculosisType I IFNsVitamin D

Identifiers

PMID31085128
PMCPMC6626683
OpenAlexW2942633246

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.